Vitiligo is a disease that can cause the loss of skin color typically in blotches and can occur when pigment-producing cells stop functioning and can be found in 1% of Americans.

We are currently conducting a clinical research study using an oral investigational medication in patients with vitiligo. We are looking for participants who meet the following criteria:

• Ages 18 or Older
• Must have a small patch (0.5%) of facial vitiligo

*Other qualifications will be checked during a screening visit with a board-certified provider. *

*Even if you do not qualify you will receive a consultation & recommendations for treatment at no cost by a board-certified provider!*

Study Duration: Approximately 14 months (eligible for another year of treatment with a study extension!)